<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Metabolism of fatty liver disease and the impact of therapy	</title>
	<atom:link href="https://biocrates.com/fatty-liver-disease-and-impact-of-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://biocrates.com/fatty-liver-disease-and-impact-of-therapy/</link>
	<description></description>
	<lastBuildDate>Tue, 15 Apr 2025 07:57:30 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>
		By: Metabolic effects of anti-TNF α therapy - biocrates life sciences gmbh		</title>
		<link>https://biocrates.com/fatty-liver-disease-and-impact-of-therapy/#comment-35</link>

		<dc:creator><![CDATA[Metabolic effects of anti-TNF α therapy - biocrates life sciences gmbh]]></dc:creator>
		<pubDate>Tue, 12 Oct 2021 08:55:01 +0000</pubDate>
		<guid isPermaLink="false">https://biocrates23.mueller-macht-web.com/?p=256700#comment-35</guid>

					<description><![CDATA[[&#8230;] metabolic effects of therapeutics in the context of liver disease. In a recent post, we showed how obeticholic acid changes the metabolome in non-alcoholic steatohepatitis [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] metabolic effects of therapeutics in the context of liver disease. In a recent post, we showed how obeticholic acid changes the metabolome in non-alcoholic steatohepatitis [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
